Coloplast leverer solidt årsregnskab i tråd med selskabets finansielle forventninger efter et stærkt fjerde kvartal
01 nov. 2021 07h35 HE
|
Coloplast A/S
Coloplast leverede en organisk vækst på 7% i 2020/21 efter et stærkt fjerde kvartal, hvor den organiske vækst var på 10%. Driftsresultatet steg 9% for året, svarende til en overskudsgrad på 33% før...
Coloplast delivers solid full year results in line with the company’s financial guidance after a strong Q4 performance
01 nov. 2021 07h35 HE
|
Coloplast A/S
The company delivered 7% organic growth in 2020/21 after a strong performance with 10% organic growth in Q4. EBIT for the full year increased by 9% corresponding to an EBIT margin of 33% before...
Øget tilskud løfter behandlingsstandarden for mennesker med neurogen blære i Polen
26 oct. 2021 03h00 HE
|
Coloplast A/S
Sammen med patientforeninger, sundhedsfagligt personale og andre grupper har Coloplast via selskabets Access to Healthcare-program støttet et projekt, der skal fremme adgangen til hydrofile katetre...
Reimbursement breakthrough in Poland raises the standard of care for people living with neurogenic bladder dysfunction
26 oct. 2021 03h00 HE
|
Coloplast A/S
Together with patient organizations, healthcare professionals and other groups, Coloplast has supported a project through the company’s Access to Healthcare programme advocating for better access to...
Coloplast åbner ny fabrik i Costa Rica
08 sept. 2021 02h00 HE
|
Coloplast A/S
Coloplast åbner i dag sin første fabrik i Mellemamerika for at understøtte den globale vækst hos selskabet, som udvikler og producerer hjælpemidler, herunder stomiposer og katetre, til mennesker med...
Coloplast opens new factory in Costa Rica
08 sept. 2021 02h00 HE
|
Coloplast A/S
Today, Coloplast opens its first factory in Central America to support the global growth of the company, which produces medical devices, including ostomy pouches and catheters, for people with...
Coloplast SenSura® Mio is Extended Wear in the US
24 août 2021 13h00 HE
|
Coloplast A/S
Ostomates now have access to a new option, as a recent patient survey showed that SenSura Mio reduces leakage while matching or outperforming the wear time of other extended wear products1. ...
Coloplast leverer en organisk vækst på 11% og en overskudsgrad på 33% i tredje kvartal
18 août 2021 06h02 HE
|
Coloplast A/S
Den organiske vækst i tredje kvartal var 11%, mens den rapporterede omsætning målt i danske kroner steg 9% til 4.835 mio. kr. Driftsresultatet (EBIT) udgjorde 1.592 mio. kr. svarende til en stigning...
Coloplast delivers 11% organic growth in Q3 and an EBIT margin of 33%
18 août 2021 06h02 HE
|
Coloplast A/S
Organic growth in Q3 was 11% and reported revenue in DKK was up by 9% to DKK 4,835 million. EBIT amounted to DKK 1,592 million, a 16% increase from last year, corresponding to an EBIT margin of 33%,...
Coloplast A/S - Announcement no. 01/2020 – Interim Financial Report, Q1 2019/20
06 févr. 2020 06h05 HE
|
Coloplast A/S
Q1 2019/20Interim financial report, Q1 2019/20(01 October 2019 - 31 December 2019) Coloplast delivers solid start to the year, guidance for 2019/20 maintained Coloplast delivered 8%...